Effect of SDZ MRL 953 on the survival of mice with advanced sepsis that cannot be cured by antibiotics alone.
Stimulation of nonspecific immunity as an additional modality for therapy of sepsis that cannot be cured by antibiotics alone was investigated. SDZ MRL 953, a novel monosaccharidic lipid A analog as a prototype immunostimulant, and cefotaxime or gentamicin were administered to normal or myelosuppres...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245040/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2039201/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.3.506 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|